Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Katherine Holton

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Clinical, Cosmetic and Investigational Dermatology|January 1, 2025
Self-Delivering RNAi Compounds for Reduction of HyperpigmentationMelissa Maxwell, Katherine Holton, Richard J Looby, et al.
Regenerative Medicine|August 30, 2008
Robust generation of hemangioblastic progenitors from human embryonic stem cellsShi-Jiang Lu, Chenmei Luo, Katherine Holton, et al.
Iscience|May 27, 2022
Self-delivering RNAi compounds as therapeutic agents in the central nervous system to enhance axonal regeneration after injurySarah A Woller, Joerg Ruschel, Barbara Morquette, et al.
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|November 5, 2013
Novel hydrophobically modified asymmetric RNAi compounds (sd-rxRNA) demonstrate robust efficacy in the eyeMichael Byrne, Radouil Tzekov, Yi Wang, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Clinical, Cosmetic and Investigational Dermatology|January 1, 2025
Self-Delivering RNAi Compounds for Reduction of HyperpigmentationMelissa Maxwell, Katherine Holton, Richard J Looby, et al.
Regenerative Medicine|August 30, 2008
Robust generation of hemangioblastic progenitors from human embryonic stem cellsShi-Jiang Lu, Chenmei Luo, Katherine Holton, et al.
Iscience|May 27, 2022
Self-delivering RNAi compounds as therapeutic agents in the central nervous system to enhance axonal regeneration after injurySarah A Woller, Joerg Ruschel, Barbara Morquette, et al.
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|November 5, 2013
Novel hydrophobically modified asymmetric RNAi compounds (sd-rxRNA) demonstrate robust efficacy in the eyeMichael Byrne, Radouil Tzekov, Yi Wang, et al.
Pageof 1